Laboratory tests and tocilizumab Archives

Abstract Number: 2363 • ACR/ARHP Annual Meeting 2014
Leucine-Rich Alpha-2 Glycoprotein Is a Potential Disease Activity Marker Under IL-6 Suppression in Autoimmune Arthritis
Yusuke Takahashi¹, Minoru Fujimoto², Satoshi Serada³ and Tetsuji Naka², ¹a doctoral student, Osaka university, Suita city, Japan, ²Laboratory for immune signal, National Institute of Biomedical Innovation, Ibaraki, Japan, ³7-6-8, Saito-asagi, National Institute of Biomedical Innovation, Laboratory for immune signal, Japan, Ibaraki, Japan
Background/Purpose C-reactive protein (CRP) is frequently used to evaluate inflammation in patients with rheumatoid arthritis (RA). However, CRP is normalized when IL-6 function is potently…
Abstract Number: 2344 • ACR/ARHP Annual Meeting 2013
Effect Of Tocilizumab On Treatment Patterns, Effectiveness and Safety With Laboratory Values For Patients With Rheumatoid Arthritis: Analyses From The Corrona-Certain Study
Dimitrios A. Pappas¹, Ani John², Joel M. Kremer³, Chitra Karki⁴, Tanya Sommers⁴, George W. Reed⁴, Jeffrey R. Curtis⁵, Ashwini Shewade² and Jeffrey D. Greenberg⁶, ¹Columbia University, New York, NY, ²Genentech Inc., South San Francisco, CA, ³Albany Medical College and The Center for Rheumatology, Albany, NY, ⁴CORRONA, Inc., Southborough, MA, ⁵Rheumatology & Immunology, University of Alabama-Birmingham, Birmingham, AL, ⁶NYU Hospital for Joint Diseases, New York, NY
Background/Purpose: Data from randomized clinical trials (RCTs) and their open-label extensions in patients (pts) with rheumatoid arthritis (RA) indicate that tocilizumab (TCZ) may be associated…

Abstracts tagged "Laboratory tests and tocilizumab"

Leucine-Rich Alpha-2 Glycoprotein Is a Potential Disease Activity Marker Under IL-6 Suppression in Autoimmune Arthritis

Effect Of Tocilizumab On Treatment Patterns, Effectiveness and Safety With Laboratory Values For Patients With Rheumatoid Arthritis: Analyses From The Corrona-Certain Study